Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy

ISSN： 1178-1661

Source： The Patient: Patient-Centered Outcomes Research, Vol.1, Iss.3, 2008-01, pp. : 181-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral fluoropyrimidine versus intravenous 5‐fluorouracil for the treatment of advanced gastric and colorectal cancer: Meta‐analysis

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 1, 2018-01 ,pp. : 209-225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 238-246

Karger

Access to resources Recommend Favorite

Costs of chemotherapy in the treatment of colorectal cancer

By Jansman F. Postma M.

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-06 ,pp. : 145-146

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy in the Treatment of Advanced Gallbladder Cancer

Oncology, Vol. 66, Iss. 2, 2004-05 ,pp. : 138-142

Karger

Access to resources Recommend Favorite

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

By Gelibter Alain J. Gamucci Teresa Pollera Camillo F. Di Costanzo Francesco Nuzzo Carmen Gabriele Angela Signorelli Carlo Gasperoni Silvia Ferraresi Virginia Giannarelli Diana Cognetti Francesco Zeuli Massimo

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2117-2123

Informa Healthcare

Access to resources Recommend Favorite